Filing Details
- Accession Number:
- 0000014272-20-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-04 18:19:42
- Reporting Period:
- 2020-03-02
- Accepted Time:
- 2020-03-04 18:19:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1677618 | Rupert Vessey | 430 E. 29Th Street 14Th Floor New York NY 10016 | Pres., Research & Early Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Acquisiton | 2020-03-02 | 43,535 | $54.94 | 82,718 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2020-03-02 | 24,466 | $54.29 | 107,184 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2020-03-02 | 8,489 | $44.70 | 115,673 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2020-03-02 | 8,489 | $47.81 | 124,162 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Acquisiton | 2020-03-02 | 8,489 | $38.41 | 132,651 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2020-03-02 | 84,308 | $60.59 | 48,343 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2020-03-02 | 43,535 | $0.00 | 43,535 | $54.94 |
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2020-03-02 | 24,466 | $0.00 | 24,466 | $54.29 |
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2020-03-02 | 8,489 | $0.00 | 8,489 | $44.70 |
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2020-03-02 | 8,489 | $0.00 | 8,489 | $47.81 |
Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2020-03-02 | 8,489 | $0.00 | 8,489 | $38.41 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
14,515 | 2026-10-31 | No | 4 | M | Direct | |
24,466 | 2027-10-30 | No | 4 | M | Direct | |
25,469 | 2028-05-08 | No | 4 | M | Direct | |
25,469 | 2028-07-30 | No | 4 | M | Direct | |
25,468 | 2028-10-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.10 Par Value | 613 | Indirect | 401(k) |
Footnotes
- 84,308 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from 60.33 to 60.71, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Based on recent 401(k) plan statement.
- All of the shares are currently exercisable.